Jae-Kyung Lim

Title: Jae-Kyung Lim: Innovator in Pharmaceutical Chemistry

Introduction

Jae-Kyung Lim is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on addressing critical health issues related to BET protein-related diseases.

Latest Patents

Jae-Kyung Lim holds a patent for a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative. This patent includes a method for preparing the compound and a pharmaceutical composition aimed at preventing or treating diseases associated with bromodomain extra-terminal (BET) proteins. These diseases include various forms of cancer and autoimmune disorders, making her invention particularly relevant in the medical field.

Career Highlights

Throughout her career, Jae-Kyung Lim has worked with prominent organizations such as Dong Wha Pharm. Co., Ltd. and the Korea Research Institute of Chemical Technology. Her experience in these institutions has allowed her to refine her expertise in pharmaceutical development and research.

Collaborations

Jae-Kyung Lim has collaborated with several professionals in her field, including Kwangho Lee and Gildon Choi. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Jae-Kyung Lim's contributions to pharmaceutical chemistry highlight her role as an innovator in the field. Her patented work on BET protein-related diseases showcases her commitment to advancing medical science and improving health outcomes.